Literature DB >> 1541412

Changes in nocturnal and peak acid outputs after duodenal ulcer healing with sucralfate or ranitidine.

A F Kummer1, D A Johnston, I N Marks, G O Young, N A Tigler-Wybrandi, S A Bridger.   

Abstract

Changes in basal and stimulated acid secretion after duodenal ulcer healing have been previously shown to be influenced by the nature of the treatment. This study aimed to determine possible changes in nocturnal acid secretion on duodenal ulcer healing in patients treated with sucralfate or ranitidine. Nocturnal acid output and peak acid output in response to pentagastrin stimulation were studied in 20 patients before and after duodenal ulcer healing with sucralfate (n = 9) or ranitidine (n = 11). Details regarding cigarette smoking were obtained from each subject. Median 10 hour nocturnal acid output fell significantly (p less than 0.05) from 82.4 (29.1-188.3) mmol (median range) to 45.2 (14.7-144.4) mmol after healing with sucralfate, and rose significantly (p less than 0.05) from 54.7 (16.8-74.3) mmol to 86.2 (11.7-118.1) mmol after ulcer healing with ranitidine. Peak acid output fell from 39.6 (22.0-52.8) mmol/hour to 27.8 (13.8-38.2) mmol/hour (p less than 0.01) after healing with sucralfate and was unchanged after healing with ranitidine. There was no correlation between smoking and nocturnal acid output. These results provide further evidence that acid secretion decreases with sucralfate healing and remains the same or may even increase after ranitidine healing.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1541412      PMCID: PMC1373925          DOI: 10.1136/gut.33.2.175

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  14 in total

1.  Recurrence of duodenal ulcer and elevated serum pepsinogen I levels in smokers and nonsmokers.

Authors:  K Sumii; M Kimura; A Morikawa; K Haruma; M Yoshihara; G Kajiyama
Journal:  Am J Gastroenterol       Date:  1990-11       Impact factor: 10.864

2.  Duodenal ulcer healing and acid secretory responses to modified sham feeding and pentagastrin stimulation.

Authors:  D A Johnston; I N Marks; G O Young; N A Tigler-Wybrandi; S Bridger
Journal:  Aliment Pharmacol Ther       Date:  1990-08       Impact factor: 8.171

3.  Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonist.

Authors:  G M Fullarton; G McLauchlan; A Macdonald; G P Crean; K E McColl
Journal:  Gut       Date:  1989-04       Impact factor: 23.059

4.  Acid, pepsin, and mucus secretion in patients with gastric and duodenal ulcer before and after colloidal bismuth subcitrate (De-Nol).

Authors:  J H Baron; J Barr; J Batten; R Sidebotham; J Spencer
Journal:  Gut       Date:  1986-05       Impact factor: 23.059

5.  Short- and long-term treatment with cimetidine in peptic ulcer disease and the pharmacokinetics of cimetidine.

Authors:  G Bodemar; B Norlander; A Walan; R Larsson
Journal:  Scand J Gastroenterol Suppl       Date:  1979

6.  Alteration of H2 receptor sensitivity in duodenal ulcer patients after maintenance treatment with an H2 receptor antagonist.

Authors:  D B Jones; C W Howden; D W Burget; C Silletti; R H Hunt
Journal:  Gut       Date:  1988-07       Impact factor: 23.059

7.  Parietal and chief cell sensitivity to histamine and pentagastrin stimulation before and after cimetidine treatment in healthy subjects.

Authors:  E Aadland; A Berstad
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423

8.  Lack of gastric acid rebound after stopping a successful short-term course of nizatidine in duodenal ulcer patients.

Authors:  V Savarino; G S Mela; P Zentilin; A Sumberaz; G Bonifacino; G Celle
Journal:  Am J Gastroenterol       Date:  1991-03       Impact factor: 10.864

9.  Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression.

Authors:  D W Burget; S G Chiverton; R H Hunt
Journal:  Gastroenterology       Date:  1990-08       Impact factor: 22.682

10.  Gastric pepsin and acid secretion in patients with acute and healed duodenal ulcer.

Authors:  J L Achord
Journal:  Gastroenterology       Date:  1981-07       Impact factor: 22.682

View more
  4 in total

1.  Helicobacter pylori eradication, duodenal ulcer healing, and gastric secretory state.

Authors:  J A Louw; I N Marks
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

Review 2.  Optimizing acid suppression for treatment of acid-related diseases.

Authors:  R H Hunt; C Cederberg; J Dent; F Halter; C Howden; I N Marks; S Rune; R P Walt
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

3.  Behaviour of acid secretion, gastrin release, serum pepsinogen I, and gastric emptying of liquids over six months from eradication of helicobacter pylori in duodenal ulcer patients. A controlled study.

Authors:  F Parente; G Maconi; O Sangaletti; M Minguzzi; L Vago; G Bianchi Porro
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

Review 4.  The H2-receptor antagonist era in duodenal ulcer disease.

Authors:  I N Marks
Journal:  Yale J Biol Med       Date:  1992 Nov-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.